Study on the optimal choice of therapeutic approaches for elderly women with advanced epithelial ovarian cancer
- VernacularTitle:老年晚期上皮性卵巢癌患者治疗方法的探讨
- Author:
Rongyu ZANG
;
Ziting LI
;
Jie TANG
;
Zhiyi ZHANG
;
Shumo CAI
- Publication Type:Journal Article
- Keywords:
Ovarian neoplasms;
Drug therapy,combination;
Prognosis
- From:
Chinese Journal of Geriatrics
2003;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
1cm, there was a significant statistical difference in median survival of 61 and 12 months, respectively (? 2 =16.60, P =0.0001). The median survival for patients with and without peritoneal chemotherapy were 27 and 12 months, respectively (? 2 =3.45, P =0.0633). Residual disease, FIGO stage, recurrent ascites, uterus muscle involvement were independent prognostic determinants of survival identified by Cox's stepwise regression analysis. Conclusions Aggressive surgical cytoreduction should be performed in elderly AEOC patients as well as in younger patients, but multi-course platinum-based chemotherapy should be used in accordance with the performance status of elder women.
